1. Home
  2. MIND vs IFRX Comparison

MIND vs IFRX Comparison

Compare MIND & IFRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MIND Technology Inc. (DE)

MIND

MIND Technology Inc. (DE)

HOLD

Current Price

$9.01

Market Cap

83.4M

Sector

Industrials

ML Signal

HOLD

Logo InflaRx N.V.

IFRX

InflaRx N.V.

HOLD

Current Price

$1.10

Market Cap

71.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MIND
IFRX
Founded
1987
2007
Country
United States
Germany
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
83.4M
71.1M
IPO Year
1994
2017

Fundamental Metrics

Financial Performance
Metric
MIND
IFRX
Price
$9.01
$1.10
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$8.50
AVG Volume (30 Days)
265.0K
666.1K
Earning Date
12-09-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.38
N/A
Revenue
$46,195,000.00
$73,729.00
Revenue This Year
N/A
N/A
Revenue Next Year
$8.08
$1,054.36
P/E Ratio
$23.50
N/A
Revenue Growth
2.21
N/A
52 Week Low
$4.45
$0.71
52 Week High
$14.50
$2.77

Technical Indicators

Market Signals
Indicator
MIND
IFRX
Relative Strength Index (RSI) 49.16 50.70
Support Level $8.65 $0.99
Resistance Level $9.25 $1.16
Average True Range (ATR) 0.57 0.08
MACD 0.13 0.01
Stochastic Oscillator 80.46 75.52

Price Performance

Historical Comparison
MIND
IFRX

About MIND MIND Technology Inc. (DE)

MIND Technology Inc provides technology and solutions for exploration, survey, and defense applications in oceanographic, hydrographic, defense, seismic, and security industries. The company operates in segments namely, Seamap Marine Products and Klein Marine Products helps manufacture and sell specialized, high-performance sonar and seismic equipment. The company generates more revenue from Seamap Marine Products. The company's geographical segments include the United States; China, Norway; Turkey; Singapore; and Canada & Other.

About IFRX InflaRx N.V.

InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.

Share on Social Networks: